Join AACE for a complimentary 5-module course designed to support clinicians in improving their knowledge of amylin biology and its potential role in the future of obesity management. Through this 120-minute, case-based activity, clinicians will develop a science-based understanding of amylin biology and awareness of the available evidence, and prepare to apply evolving obesity science responsibly in everyday clinical practice. Each interactive module explores emerging processes, continuing research, and how amylin-based methods may eventually merge into complication-centric obesity management strategies.
Intended for endocrinologists, obesity medicine specialists, and primary care professionals (PCPs), this activity highlights clinical reasoning and interpretation of evolving data while distinguishing established standards of care from investigational approaches. Learn from leading experts in the field and advance your practice today - and earn up to 2 AMA PRA Category 1 Credits.
11/18/2026
11/18/2027
By the end of the activity, participants will be able to:
- Describe the physiologic role of amylin in energy balance, appetite regulation, and metabolic control, and how it complements other hormonal pathways involved in obesity.
- Summarize emerging (Phases 2 and 3) clinical evidence on amylin-based therapies and their potential role in the future management of obesity.
- Integrate evolving amylin science into a broader, mechanism-based framework for individualized obesity treatment, while clearly distinguishing current evidence from investigational approaches.
The target audience for this program is U.S.-based endocrinologists, obesity medicine specialists, and primary care professionals (PCPs) including physicians, nurse practitioners, nurses, physician assistants, and other members of the endocrine care team involved in obesity management.
SPEAKERS
FACULTY
Domenica Rubino, MD
Director, Washington Center for Weight Management and Research
Arlington, VA
Meera Shah, MBChB
Mayo Clinic
Rochester, MN
Michael Weintraub, MD
NYU Langone Health
New York, NY
This activity is supported by an educational grant from Novo Nordisk.